TY - JOUR
T1 - Kidney Disease
T2 - End-Stage Renal Disease
AU - Braun, Michael M.
AU - Khayat, Maurice
N1 - Publisher Copyright:
Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - End-stage renal disease (ESRD) affects approximately 745,000 individuals in the United States. Patients with ESRD are dependent on renal replacement therapy (RRT) via dialysis or kidney transplantation. The two dialysis modalities are peritoneal dialysis and hemodialysis. No differences in long-term mortality rates between the two modalities have been shown. Peritoneal dialysis is performed at home. Hemodialysis typically is performed at a dialysis center through vascular access via an arteriovenous fistula (which must mature for several months before use), an arteriovenous graft (which can be used in as few as 24 hours, depending on the graft material), or a central venous catheter (usable immediately but associated with the highest risk of infection). Transplantation is the treatment of choice for patients with ESRD, and referral should be offered to patients who are candidates. However, some patients with ESRD decide against RRT and opt for supportive care. For these patients, and for patients who choose to discontinue dialysis, palliative care and hospice referral are indicated. For all patients with advanced chronic kidney disease or ESRD, treatment includes management of complications, including hyperkalemia, hypervolemia, metabolic acidosis, anemia, mineral and bone disorders, and protein-calorie malnutrition.
AB - End-stage renal disease (ESRD) affects approximately 745,000 individuals in the United States. Patients with ESRD are dependent on renal replacement therapy (RRT) via dialysis or kidney transplantation. The two dialysis modalities are peritoneal dialysis and hemodialysis. No differences in long-term mortality rates between the two modalities have been shown. Peritoneal dialysis is performed at home. Hemodialysis typically is performed at a dialysis center through vascular access via an arteriovenous fistula (which must mature for several months before use), an arteriovenous graft (which can be used in as few as 24 hours, depending on the graft material), or a central venous catheter (usable immediately but associated with the highest risk of infection). Transplantation is the treatment of choice for patients with ESRD, and referral should be offered to patients who are candidates. However, some patients with ESRD decide against RRT and opt for supportive care. For these patients, and for patients who choose to discontinue dialysis, palliative care and hospice referral are indicated. For all patients with advanced chronic kidney disease or ESRD, treatment includes management of complications, including hyperkalemia, hypervolemia, metabolic acidosis, anemia, mineral and bone disorders, and protein-calorie malnutrition.
UR - http://www.scopus.com/inward/record.url?scp=85118903222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118903222&partnerID=8YFLogxK
M3 - Article
C2 - 34643362
AN - SCOPUS:85118903222
SN - 2159-3000
VL - 509
SP - 26
EP - 32
JO - FP essentials
JF - FP essentials
ER -